Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Biomarkers for a therapy comprising a sorafenib compound

Biomarkers for a therapy comprising a sorafenib compound

US Patent 12504431 · Granted Dec 23, 2025

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Therapeutic agent for breast cancer2025
Therapeutic agent for bile duct cancer2025
Pharmaceutical composition for treating tumor2024
Biomarkers for predicting and assessing responsiveness of thyroid and kidney can2023
Therapeutic agent for hepatocellular carcinoma2022
Pharmaceutical composition for treating tumor2021
Combination of a PD-1 antagonist and eribulin for treating cancer2021
Biomarkers for predicting and assessing responsiveness of endometrial cancer sub2019
Biomarkers for predicting and assessing responsiveness of thyroid and kidney can2018
Antitumor agent using compounds having kinase inhibitory effect in combination2015
Notch-based fusion proteins and uses thereof2015
Therapeutic agent for tumor2015